WO2023002246 - NOVEL 1,2-DIAMINOBENZIMIDAZOLE DERIVATIVE
National phase entry:
Publication Number
WO/2023/002246
Publication Date
26.01.2023
International Application No.
PCT/IB2022/000396
International Filing Date
21.07.2022
Title **
[English]
NOVEL 1,2-DIAMINOBENZIMIDAZOLE DERIVATIVE
[French]
NOUVEAU DÉRIVÉ DE 1,2-DIAMINOBENZIMIDAZOLE
Applicants **
CARNA BIOSCIENCES, INC.
Inventors
MATSUMOTO, Hirokazu
KIYOI, Takao
TAKAMATSU, Shiori
SAWA, Masaaki
Priority Data
2021-120698
21.07.2021
JP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1417 | |
| EPO | Filing, Examination, Granting | 12164 | |
| Japan | Filing, Examination, Granting | 1613 | |
| South Korea | Filing, Examination, Granting | 1106 | |
| USA | Filing, Examination, Granting | 3490 |
Total:
19,790
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
are defined in the specification.[French]
sont tels que définis dans la description.